semaglutide approved by fda The has the first GLP-1 pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular FDA Approves Oral Semaglutide for

You can stop taking Semaglutide injections once your target weight loss is achieved, though you should always speak to us beforehand

These can include nausea, diarrhea, and potential rare but serious side effects such as pancreatitis or thyroid tumors

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

If you develop severe abdominal pain, persistent vomiting, or back pain while on GLP-1 treatment, seek immediate medical attention and contact PlexusDx to pause therapy pending evaluation

The genetic test reveals your predispositions in peptide pathways, which should be interpreted alongside clinical observation, tolerability assessment, and provider guidance

PMID: 34361586